GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bausch Health Companies Inc (TSX:BHC) » Definitions » EV-to-Revenue

Bausch Health (TSX:BHC) EV-to-Revenue

: 2.87 (As of Today)
View and export this data going back to 1987. Start your Free Trial

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Bausch Health's enterprise value is C$33,863 Mil. Bausch Health's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was C$11,798 Mil. Therefore, Bausch Health's EV-to-Revenue for today is 2.87.

The historical rank and industry rank for Bausch Health's EV-to-Revenue or its related term are showing as below:

TSX:BHC' s EV-to-Revenue Range Over the Past 10 Years
Min: 2.82   Med: 3.75   Max: 13.95
Current: 2.87

During the past 13 years, the highest EV-to-Revenue of Bausch Health was 13.95. The lowest was 2.82. And the median was 3.75.

TSX:BHC's EV-to-Revenue is ranked worse than
58.87% of 1026 companies
in the Drug Manufacturers industry
Industry Median: 2.315 vs TSX:BHC: 2.87

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-04-16), Bausch Health's stock price is C$11.89. Bausch Health's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was C$32.28. Therefore, Bausch Health's PS Ratio for today is 0.37.


Bausch Health EV-to-Revenue Historical Data

The historical data trend for Bausch Health's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bausch Health Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.85 3.83 3.79 2.88 2.89

Bausch Health Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-Revenue Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.88 3.02 2.81 3.00 2.89

Competitive Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Bausch Health's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bausch Health EV-to-Revenue Distribution

For the Drug Manufacturers industry and Healthcare sector, Bausch Health's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Bausch Health's EV-to-Revenue falls into.



Bausch Health EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Bausch Health's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=33863.134/11797.862
=2.87

Bausch Health's current Enterprise Value is C$33,863 Mil.
Bausch Health's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$11,798 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bausch Health  (TSX:BHC) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Bausch Health's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=11.89/32.276
=0.37

Bausch Health's share price for today is C$11.89.
Bausch Health's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$32.28.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bausch Health EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Bausch Health's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Bausch Health (TSX:BHC) Business Description

Traded in Other Exchanges
Address
2150 Saint Elzear Boulvard West, Laval, QC, CAN, H7L 4A8
Bausch Health Companies Inc is a global specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the dermatology, gastrointestinal, and ophthalmology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.

Bausch Health (TSX:BHC) Headlines

From GuruFocus